University of North Carolina - Chapel Hill Endowment Fund

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private, Subsidiary

Employees: -

Market Cap: -

Website

Clinical Trials

Topical Budesonide Treatment for Eosinophilic Esophagitis (EoE)

Not Applicable

Completed

Conditions: Eosinophilic Esophagitis

Interventions: Drug: inhaled/swallowed budesonide
Drug: viscous/swallowed budesonide

First Posted Date: 2009-08-18

Last Posted Date: 2012-11-06

Lead Sponsor: University of North Carolina, Chapel Hill

Target Recruit Count: 25

Registration Number: NCT00961233

Locations: 🇺🇸
University of North Carolina, Chapel Hill, North Carolina, United States

Evaluating Once Daily Etravirine in Treatment-Naive Adults With HIV Infection

Phase 2

Completed

Conditions: HIV Infections

Interventions: Drug: Etravirine (Intelence)
Drug: Truvada

First Posted Date: 2009-08-17

Last Posted Date: 2016-06-06

Lead Sponsor: University of North Carolina, Chapel Hill

Target Recruit Count: 80

Registration Number: NCT00959894

Locations: 🇺🇸
Wake Forest University Health Sciences, Winston-Salem, North Carolina, United States
🇺🇸
The University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, United States
🇺🇸
Carolinas Medical Center, Charlotte, North Carolina, United States

Computerized HIV/Sexually Transmitted Disease (STD) Prevention Program

Phase 2

Completed

Conditions: Acquired Immunodeficiency Syndrome
HIV Infections

Interventions: Behavioral: Tailored Information Program for Safer Sex

First Posted Date: 2009-07-28

Last Posted Date: 2013-11-15

Lead Sponsor: University of North Carolina, Chapel Hill

Target Recruit Count: 274

Registration Number: NCT00947947

Locations: 🇺🇸
Specialty Clinic, Louisville Metro Health Department, Louisville, Kentucky, United States

Treatment for Periodontal Disease in Dialysis Patients

Not Applicable

Completed

Conditions: Periodontal Disease

Interventions: Procedure: Periodontal Scaling and Root Planing

First Posted Date: 2009-07-13

Last Posted Date: 2012-05-07

Lead Sponsor: University of North Carolina, Chapel Hill

Target Recruit Count: 60

Registration Number: NCT00937976

Locations: 🇺🇸
GO Health Center, School of Dentistry, University of North Carolina-Chapel Hill, Chapel Hill, North Carolina, United States

Effect of Lucinactant on Mucus Clearance in Cystic Fibrosis Lung Disease

Phase 2

Completed

Conditions: Cystic Fibrosis

Interventions: Drug: Placebo first
Drug: Lucinactant first

First Posted Date: 2009-07-08

Last Posted Date: 2017-03-13

Lead Sponsor: University of North Carolina, Chapel Hill

Target Recruit Count: 16

Registration Number: NCT00934362

Locations: 🇺🇸
University of North Carolina, Chapel Hill, North Carolina, United States

Burn Healing and Analgesia With Propranolol

Phase 2

Completed

Conditions: Pain
Burns

Interventions: Drug: Placebo
Drug: Propranolol
Drug: Propanolol

First Posted Date: 2009-07-08

Last Posted Date: 2017-11-17

Lead Sponsor: University of North Carolina, Chapel Hill

Target Recruit Count: 45

Registration Number: NCT00934947

Locations: 🇺🇸
Washington Hospital Center, Washington, D.C., District of Columbia, United States
🇺🇸
North Carolina Jaycee Burn Center, Chapel Hill, North Carolina, United States
🇺🇸
Crozer Chester Medical Center, Upland, Pennsylvania, United States

and more 1 locations

Peanut Oral Immunotherapy and Anti-Immunoglobulin E (IgE) for Peanut Allergy

Phase 1

Completed

Conditions: Peanut Hypersensitivity

Interventions: Drug: Peanut Oral Immunotherapy
Drug: Omalizumab

First Posted Date: 2009-07-03

Last Posted Date: 2018-03-01

Lead Sponsor: University of North Carolina, Chapel Hill

Target Recruit Count: 13

Registration Number: NCT00932282

Locations: 🇺🇸
University of North Carolina, Chapel Hill, North Carolina, United States

Determining the Efficacy and Value of Immunotherapy on the Likelihood of Peanut Tolerance: The DEVIL Study

Phase 2

Completed

Conditions: Food Hypersensitivity

Interventions: Drug: Peanut oral immunotherapy

First Posted Date: 2009-07-03

Last Posted Date: 2018-05-24

Lead Sponsor: University of North Carolina, Chapel Hill

Target Recruit Count: 37

Registration Number: NCT00932828

Locations: 🇺🇸
University of North Carolina, Chapel Hill, North Carolina, United States

UCAN: Uniting Couples in the Treatment of Anorexia Nervosa

Not Applicable

Completed

Conditions: Anorexia Nervosa

Interventions: Behavioral: CBCT
Behavioral: Family Supportive Therapy

First Posted Date: 2009-06-25

Last Posted Date: 2012-11-09

Lead Sponsor: University of North Carolina, Chapel Hill

Target Recruit Count: 40

Registration Number: NCT00928109

Locations: 🇺🇸
UNC Chapel Hill, Chapel Hill, North Carolina, United States

Continuous Oral Contraceptive Treatment in Premenstrual Dysphoric Disorder (PMDD)

Phase 4

Completed

Conditions: Premenstrual Dysphoric Disorder

Interventions: Drug: Continuous OC (EE/DROS)
Drug: Intermittent OC (EE/DROS)
Drug: placebo

First Posted Date: 2009-06-24

Last Posted Date: 2016-08-24

Lead Sponsor: University of North Carolina, Chapel Hill

Target Recruit Count: 67

Registration Number: NCT00927095

Locations: 🇺🇸
University of North Carolina, Chapel Hill, North Carolina, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy